3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Gastrointestinal
1
Conditions
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Gastrointestinal Neoplasms
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
14
Whole-Body Irradiation
11
Mycophenolic Acid
9
Epoetin Alfa
9
Cyclosporine
9
Busulfan
9
fludarabine
8
Cord Blood Stem Cell Transplantation
8
Antilymphocyte Serum
8
Filgrastim
6
Tacrolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Methotrexate
5
Darbepoetin alfa
5
Dalteparin
5
Cytarabine
5
eltrombopag
4
Tinzaparin
4
Thiotepa
4
Platelet Transfusion
4
Melphalan
4
Etoposide
4
Arsenic Trioxide
4
thymoglobulin
3
epoetin beta
3
Vorinostat
3
Transplantation
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
MAA868
×
Classical hematology
×
Clear all
NCT05171075
2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Terminated
417 enrolled
NCT05171049
2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3
Terminated
1,150 enrolled